Consolidated Statements of Cash Flows (USD $) In Thousands	12 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2009
Cash flows from operating activities:
Net income	$ 77,299	$ 29,422	$ 41,357
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, depletion and amortization	67,399	53,793	32,578
Gain on distribution to non-controlling interest	(3,258)	(5,891)	(1,924)
Deferred tax expense (benefit)	(5,136)	(7,536)	(2,170)
Non-cash employee stock compensation expense	6,494	7,279	2,921
Gain on royalty restructuring			(33,714)
Tax benefit of stock-based compensation exercises	(1,325)	(1,638)	(334)
Other		371
Changes in assets and liabilities:
Royalty receivables	(8,465)	(19,055)	(4,280)
Prepaid expenses and other assets	2,247	4,035	(477)
Accounts payable	(930)	(10,742)	(1,834)
Income taxes (receivable) payable	5,527	(2,697)	(147)
Other liabilities	7,105	1,030	(1,929)
Net cash provided by operating activities	146,957	48,371	30,047
Cash flows from investing activities:
Acquisition of royalty interests in mineral properties	(280,009)	(232,996)	(186,110)
Acquisition of International Royalty Corporation, net of cash acquired		(270,233)
Acquisition of available for sale securities	(28,574)
Proceeds from royalty restructuring			34,897
Change in restricted cash - compensating balance		19,250	(3,500)
Proceeds on sale of inventory - restricted	5,097	3,647	3,477
Deferred acquisition costs	(117)	(120)	(1,021)
Other	(2,660)	(86)	(284)
Net cash used in investing activities	(306,263)	(480,538)	(152,541)
Cash flows from financing activities:
Borrowings from credit facilities	19,500	255,000
Tax benefit of stock-based compensation exercises	1,325	1,638	334
(Prepayment of) borrowings under Chilean loan facility		(19,250)	3,500
Common stock dividends	(22,130)	(14,628)	(10,242)
Repayment of debt	(41,900)	(36,013)
Proceeds from foreign exchange contract		4,101
Distribution to non-controlling interests	(7,158)	(3,647)	(3,477)
Net proceeds from issuance of common stock		276,839	235,707
Debt issuance costs	(968)	(1,593)	(797)
Other	(54)
Net cash (used in) provided by financing activities	(51,385)	462,447	225,025
Net (decrease) increase in cash and equivalents	(210,691)	30,280	102,531
Cash and equivalents at beginning of period	324,846	294,566	192,035
Cash and equivalents at end of period	$ 114,155	$ 324,846	$ 294,566